Delivery Order SPE2DB24D1007-SPE2DB25FCAEB
Award Date 2/6/25
Potential Completion Date 2/7/25
Potential Value $2.7K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $11,731.88 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of DAPAGLIFLOZIN 10 MG TABLET 30S. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical...
- This is a $7,387.44 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4564996305 - DAPAGLIFLOZIN 10 MG TABLET 30S, a medication used to treat diabetes. The contract has an ultimate completion date of June 26, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with...
- This is a $5,975.10 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DAPAGLIFLOZIN 10 MG TABLET 30S, a diabetes medication, with a performance period ending on June 5, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that AmerisourceBergen holds with the DLA Troop Support...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,992.41, is for the delivery of DAPAGLIFLOZIN 10 MG TABLET 30S, a medication used to treat diabetes. The contract has an ultimate completion date of October 30, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,762.40, is for the delivery of DAPAGLIFLOZIN 10 MG TABLET 30S, a medication used to treat diabetes. The contract has an ultimate completion date of March 12, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with...
- This is a $16,574.98 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4564755292 - Dapagliflozin 10 mg Tablets, without any set-aside designation. The award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,774.52 Firm Fixed Price Delivery Order supports the supply of DAPAGLIFLOZIN 10 MG TABLET 30S, a pharmaceutical product, with an ultimate completion date of January 3, 2025. The award is part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,652.39 contract is for the delivery of DAPAGLIFLOZIN 10 MG TABLET 30S, a diabetes medication, with a completion date of June 12, 2025. The award is not set aside and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with DLA Troop Support Medical, which...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,386.21 firm fixed price delivery order is for the supply of DAPAGLIFLOZIN 10 MG TABLET 30S, a diabetes medication, with a completion date of July 8, 2025. The contract is not set aside and is part of Amerisourcebergen's broader $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,789.82 contract is for the delivery of Dapagliflozin 10 mg tablets. It is not set aside and has an ultimate completion date of June 10, 2025. The award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that AmerisourceBergen holds with the DLA Troop Support...